I especially appreciated the chance to chat with the other attendees from the pharmaceutical industry and EU regulators. We often started with DDI discussions but ended up learning so much more about different areas.
I especially appreciated the chance to chat with the other attendees from the pharmaceutical industry and EU regulators. We often started with DDI discussions but ended up learning so much more about different areas.